On Wednesday, the U.S. Food and Drug Administration authorized the Moderna and Pfizer-BioNTech Bivalent COVID-19 vaccines to be used as a booster dose. According to the FDA, these vaccines “include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.”
Regarding availability in Montgomery County, the Department of Health and Human Services tweeted: “Once the vaccines receive final approval from @CDCgov, we must wait for vaccine supply and written guidance from @MDHealthDept. We will keep you posted.”